0000914190-17-000265.txt : 20170901
0000914190-17-000265.hdr.sgml : 20170901
20170901164032
ACCESSION NUMBER: 0000914190-17-000265
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170830
FILED AS OF DATE: 20170901
DATE AS OF CHANGE: 20170901
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brown Edward M
CENTRAL INDEX KEY: 0001370333
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-52082
FILM NUMBER: 171066719
MAIL ADDRESS:
STREET 1: 1129 N. MCDOWELL BLVD.
CITY: PETALUMA
STATE: CA
ZIP: 94954
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cardiovascular Systems Inc
CENTRAL INDEX KEY: 0001180145
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 411698056
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 1225 OLD HWY 8 NW
CITY: ST. PAUL
STATE: MN
ZIP: 55112
BUSINESS PHONE: 651-259-1600
MAIL ADDRESS:
STREET 1: 1225 OLD HWY 8 NW
CITY: ST. PAUL
STATE: MN
ZIP: 55112
FORMER COMPANY:
FORMER CONFORMED NAME: REPLIDYNE INC
DATE OF NAME CHANGE: 20020813
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2017-08-30
0001180145
Cardiovascular Systems Inc
CSII
0001370333
Brown Edward M
1225 OLD HIGHWAY 8 NW
ST. PAUL
MN
55112
1
0
0
0
Common Stock
2017-08-30
4
S
0
13031
29.0893
D
114390
I
By Trust
Common Stock
2017-08-31
4
S
0
6969
29.3034
D
107421
I
By Trust
Restricted Stock Units
Common Stock
75536
75536
D
Restricted Stock Units
Common Stock
4029
4029
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.25 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.26 to $29.32 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Each restricted stock unit represents the right to receive a payment from CSI equal in value to the market price per share of CSI common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of each director's board membership.
Represents the aggregate number of restricted stock units (all previously reported) held by reporting person that are payable in cash or shares of Company common stock beginning six months following the termination of each director's board membership.
Each restricted stock unit represents the right to receive a payment from CSI equal in value to the market price per share of CSI common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of each director's board membership; provided, however, that the restricted stock units vest in quarterly amounts of 1,008 shares on September 30, 2017 and 1,007 shares on each of December 31, 2017, March 31, 2018 and June 30, 2018.
/s/ Ashley Brosius as Attorney-in-Fact for Edward M. Brown pursuant to Power of Attorney previously filed.
2017-09-01